News

HP Inc. Reports Robust Q4 Results Amidst Stock Fluctuation

HP Inc. Reports Robust Q4 Results Amidst Stock Fluctuation

HP Inc.'s Impressive Fourth Quarter Performance

HP Inc. (NYSE: HPQ) recently unveiled its fourth-quarter results, showcasing a blend of solid financial metrics against the backdrop of market reactions. The company managed to report earnings of 93 cents per share, meeting the analyst consensus expectations. This marks a noteworthy outcome in a competitive landscape.

Key Financial Metrics from the Quarter

The revenue figures showed a remarkable $14.05 billion, surpassing the analyst consensus estimate of $13.99 billion. In addition, this amount represents a healthy increase compared to the previous year's revenue of $13.82 billion, underscoring the company's positive growth trajectory.

Cash Flow and Operational Insights

HP's operational cash flow in the fourth quarter reached an impressive $1.6 billion. The company also reported an accounts receivable position of $5.1 billion, which reflects a two-day increase in the collection period compared to the previous quarter, now standing at 33 days. Moreover, inventory levels decreased, ending at $7.7 billion, which denotes a drop of four days in terms of inventory turnover to 63 days.

Liabilities and Free Cash Flow Performance

HP recorded accounts payable of $16.9 billion, which reflects a rise of seven days in payment terms, resulting in a total of 138 days. Additionally, the company generated $1.5 billion in free cash flow during this quarter, illustrating strong liquidity management.

Dividend Increase and Stockholder Confidence

In a positive signal for investors, HP announced a 5% increase in its annual dividend, raising the quarterly cash payment from $0.2756 to $0.2894 per share. Such decisions typically reflect a company's commitment to returning value to shareholders and can enhance stockholder confidence.

Leadership Insights and Future Outlook

According to Enrique Lores, the president and CEO of HP, the company was pleased with its Q4 performance. Lores stated, "We are pleased with our Q4 performance where we saw revenue growth for the second consecutive quarter, driven by steady progress in Personal Systems and Print." This growing momentum aims to position HP favorably for future opportunities.

Guidance for the Upcoming Fiscal Year

Looking ahead, HP anticipates first-quarter adjusted earnings to range between 70 cents and 76 cents per share, a figure that falls short of the analyst estimate of 85 cents. For the fiscal year 2025, the expected earnings range is between $3.45 and $3.75 per share, compared to the $3.60 analyst estimate. This outlook suggests a conservatively cautious approach that reflects current market conditions.

Market Reaction to Earnings Announcement

Following the announcement of these results, HP shares experienced a decline, reflecting a 7.93% drop during after-hours trading, positioning shares at $36. This reaction highlights the ongoing volatility and investor sentiment driven by forward guidance and market expectations.

Conclusion: A Mixed Bag of Results

HP Inc.'s fourth-quarter results provide a mixed perspective, showcasing solid revenue growth and operational performance against a backdrop of stock fluctuations. As they prepare for the upcoming year, stakeholders will be keenly observing HP's ability to navigate challenges and leverage growth opportunities in a dynamic market environment.

Frequently Asked Questions

What were HP's earnings per share for Q4?

HP reported earnings of 93 cents per share for the fourth quarter.

How much revenue did HP generate in Q4?

The company generated $14.05 billion in revenue for the fourth quarter.

What changes were made to HP's dividend?

HP raised its quarterly cash dividend by 5%, increasing it from $0.2756 to $0.2894 per share.

What is HP's outlook for Q1 of the next fiscal year?

HP expects adjusted earnings for Q1 to be between 70 cents and 76 cents per share.

How did the market react to HP's Q4 results?

HP shares fell by 7.93% in after-hours trading after announcing its fourth-quarter results.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles